サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542405

静脈注射用（IV）溶液の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Intravenous Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 222 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
静脈注射用（IV）溶液の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈注射用（IV）溶液市場の世界需要は、2023年の179億9,000万米ドルから2032年には354億9,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは7.84%です。

静脈注射用（IV）溶液は、治療目的で薬物、栄養剤、輸液を投与するために患者の静脈に直接投与される滅菌液です。これらの溶液は、経口的に水分を摂取できない患者や、薬剤を即座に吸収する必要のある患者にとって、医療現場で不可欠なものです。点滴液には通常、水、電解質（ナトリウム、カリウム、塩化物）がバランスよく配合され、ブドウ糖や薬剤などの追加物質が含まれることもあります。静脈注射用（IV）溶液は、水分補給と電解質バランスの維持に不可欠な役割を果たし、手術中の患者さんや病気の回復中の患者さん、慢性疾患の管理中の患者さんの生命維持機能をサポートします。輸液には様々な種類と組成があり、特定の医療ニーズや治療要件に合わせてカスタマイズされ、正確な送達と治療効果を保証します。

市場力学

慢性疾患、手術、医療緊急事態の増加により、水分補給、薬物投与、栄養補給のための信頼性の高い静脈注射用（IV）溶液が必要とされています。輸液ポンプやカテーテル設計の改良など医療技術の進歩は、静脈内投与の安全性と効率を高め、患者の転帰改善と入院期間の短縮に寄与しています。高齢化や複雑な疾患の増加といった人口動態の動向は、市場成長の原動力となっています。静脈注射用（IV）溶液の需要は、患者が継続的な治療管理のために便利で持ち運び可能な点滴オプションを必要とする外来患者ケアや在宅ヘルスケア環境の拡大により、さらに高まっています。

スマート点滴ポンプや統合電子カルテなど、点滴治療における技術革新は治療精度と患者モニタリングを向上させ、ヘルスケア施設全体での採用を促進しています。さらに、患者の安全性と品質基準を向上させるための規制当局の取り組みは、準拠した静脈注射用（IV）溶液メーカーが市場でのプレゼンスを拡大し、新製品を革新する機会を生み出しています。製薬会社、医療機器メーカー、医療提供者の戦略的提携は、製品開発と流通を促進し、市場競争力と拡張性を世界的に高めています。しかし、製品承認のための厳しい規制要件やヘルスケアシステムにおける価格決定力学が市場成長の妨げとなっています。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは静脈注射用（IV）溶液の世界市場における各セグメントを包括的に評価することもできます。静脈注射用（IV）溶液産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

静脈注射用（IV）溶液市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後の機会を支援します。

タイプ別

  • 全身非経口栄養
  • 末梢非経口栄養

組成別

  • 炭水化物
  • ビタミンおよびミネラル
  • 単回投与アミノ酸
  • 非経口脂質エマルジョン
  • その他の組成

年齢別

  • 小児
  • 成人
  • 老人

用途別

  • 栄養サポート
  • 輸血
  • 輸液・電解質バランス
  • その他の用途

エンドユーザー別

  • 病院およびクリニック
  • 外来手術センター
  • 在宅ケア

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの静脈注射用（IV）溶液市場の現在と将来の需要を強調する地域展望をカバーします。さらに、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 静脈注射用（IV）溶液-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 静脈注射用（IV）溶液の世界市場分析：タイプ別

  • タイプ別概要
  • タイプ別過去および予測データ分析
  • 全身非経口栄養
  • 末梢非経口栄養

第6章 静脈注射用（IV）溶液の世界市場分析：組成別

  • 組成別概要
  • 組成別過去および予測データ分析
  • 炭水化物
  • ビタミンおよびミネラル
  • 単回投与アミノ酸
  • 非経口脂質エマルジョン
  • その他の組成

第7章 静脈注射用（IV）溶液の世界市場分析：年齢別

  • 年齢別概要
  • 年齢別過去および予測データ分析
  • 小児
  • 成人
  • 老人

第8章 静脈注射用（IV）溶液の世界市場分析：用途別

  • 概要：用途別
  • 用途別過去および予測データ分析
  • 栄養サポート
  • 輸血
  • 輸液・電解質バランス
  • その他の用途

第9章 静脈注射用（IV）溶液の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去および予測データ分析
  • 病院およびクリニック
  • 外来手術センター
  • 在宅ケア

第10章 静脈注射用（IV）溶液の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 輸液メーカーの競合情勢

  • 静脈注射用（IV）溶液市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Ajinomoto Co Inc.
  • Amanta Healthcare
  • Axa Parenterals Ltd
  • B.Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi USA LLC
  • Grifols S.A.
  • ICU Medical Inc
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd
  • Pfizer Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Total Parenteral Nutrition Market Sales By Geography (USD MN)
  • Peripheral Parenteral Nutrition Market Sales By Geography (USD MN)
  • Analysis By Composition (USD MN)
  • Carbohydrates Market Sales By Geography (USD MN)
  • Vitamins & Minerals Market Sales By Geography (USD MN)
  • Single-Dose Amino Acids Market Sales By Geography (USD MN)
  • Parenteral Lipid Emulsion Market Sales By Geography (USD MN)
  • Other Compositions Market Sales By Geography (USD MN)
  • Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Geriatric Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Nutritional Support Market Sales By Geography (USD MN)
  • Blood Transfusion Market Sales By Geography (USD MN)
  • Fluid & Electrolyte Balance Market Sales By Geography (USD MN)
  • Other Applications Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals And Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgery Centers Market Sales By Geography (USD MN)
  • Home Care Setting Market Sales By Geography (USD MN)
  • Global Intravenous Solutions Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Intravenous Solutions Report
  • Market Research Process
  • Market Research Methodology
  • Global Intravenous Solutions Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Composition
  • Market Attractiveness Analysis By Age Group
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Total Parenteral Nutrition Market Sales By Geography (USD MN)
  • Peripheral Parenteral Nutrition Market Sales By Geography (USD MN)
  • Global Market Analysis By Composition (USD MN)
  • Carbohydrates Market Sales By Geography (USD MN)
  • Vitamins & Minerals Market Sales By Geography (USD MN)
  • Single-Dose Amino Acids Market Sales By Geography (USD MN)
  • Parenteral Lipid Emulsion Market Sales By Geography (USD MN)
  • Other Compositions Market Sales By Geography (USD MN)
  • Global Market Analysis By Age Group (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Geriatric Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Nutritional Support Market Sales By Geography (USD MN)
  • Blood Transfusion Market Sales By Geography (USD MN)
  • Fluid & Electrolyte Balance Market Sales By Geography (USD MN)
  • Other Applications Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals And Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgery Centers Market Sales By Geography (USD MN)
  • Home Care Setting Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219483

The global demand for Intravenous Solutions Market is presumed to reach the market size of nearly USD 35.49 Billion by 2032 from USD 17.99 Billion in 2023 with a CAGR of 7.84% under the study period 2024-2032.

Intravenous (IV) solutions are sterile fluids administered directly into a patient's veins to deliver medications, nutrients, or fluids for therapeutic purposes. These solutions are essential in medical settings for patients who cannot consume liquids orally or require immediate absorption of medications. Intravenous solutions typically contain a balanced combination of water, electrolytes (sodium, potassium, and chloride), and sometimes additional substances like glucose or medications. They play an integral role in maintaining hydration & electrolyte balance and supporting vital functions in patients undergoing surgery, recovering from illnesses, or managing chronic conditions. IV solutions are available in various types and compositions, which are customized to meet specific medical needs and treatment requirements, ensuring precise delivery and therapeutic efficacy.

MARKET DYNAMICS

The increasing prevalence of chronic diseases, surgeries, and medical emergencies necessitates reliable intravenous solutions for fluid replacement, medication delivery, and nutritional support. Advances in medical technology, such as improved infusion pumps and catheter designs, enhance the safety and efficiency of IV administration, contributing to better patient outcomes and reduced hospital stays. Demographic trends such as aging populations and the rising incidence of complex diseases drive market growth. The demand for intravenous solutions is further bolstered by the expansion of outpatient care and home healthcare settings, where patients require convenient and portable infusion options for continuous therapy management.

Technological innovations in IV therapy, including smart IV pumps and integrated electronic medical records, improve treatment precision and patient monitoring, promoting adoption across healthcare facilities. Moreover, regulatory initiatives to enhance patient safety and quality standards create opportunities for compliant intravenous solutions manufacturers to expand their market presence and innovate new products. Strategic collaborations among pharmaceutical companies, medical device manufacturers, and healthcare providers facilitate product development and distribution, enhancing market competitiveness and scalability globally. However, stringent regulatory requirements for product approval and pricing dynamics in healthcare systems hampers market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intravenous Solutions. The growth and trends of Intravenous Solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intravenous Solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

By Composition

  • Carbohydrates
  • Vitamins & Minerals
  • Single-Dose Amino Acids
  • Parenteral Lipid Emulsion
  • Other Compositions

By Age Group

  • Pediatric
  • Adult
  • Geriatric

By Application

  • Nutritional Support
  • Blood Transfusion
  • Fluid & Electrolyte Balance
  • Other Applications

By End-User

  • Hospitals And Clinics
  • Ambulatory Surgery Centers
  • Home Care Setting

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intravenous Solutions market include Ajinomoto Co Inc., Amanta Healthcare, Axa Parenterals Ltd, B.Braun Melsungen AG, Baxter International Inc., Fresenius Kabi USA LLC, Grifols S.A., ICU Medical Inc, JW Life Science, Otsuka Pharmaceutical Co. Ltd, Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. INTRAVENOUS SOLUTIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Composition
    • 3.7.3 Market Attractiveness Analysis By Age Group
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End-User
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Total Parenteral Nutrition Historic and Forecast Sales By Regions
  • 5.4. Peripheral Parenteral Nutrition Historic and Forecast Sales By Regions

6. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY COMPOSITION

  • 6.1. Overview By Composition
  • 6.2. Historical and Forecast Data Analysis By Composition
  • 6.3. Carbohydrates Historic and Forecast Sales By Regions
  • 6.4. Vitamins & Minerals Historic and Forecast Sales By Regions
  • 6.5. Single-Dose Amino Acids Historic and Forecast Sales By Regions
  • 6.6. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
  • 6.7. Other Compositions Historic and Forecast Sales By Regions

7. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY AGE GROUP

  • 7.1. Overview By Age Group
  • 7.2. Historical and Forecast Data Analysis By Age Group
  • 7.3. Pediatric Historic and Forecast Sales By Regions
  • 7.4. Adult Historic and Forecast Sales By Regions
  • 7.5. Geriatric Historic and Forecast Sales By Regions

8. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data Analysis By Application
  • 8.3. Nutritional Support Historic and Forecast Sales By Regions
  • 8.4. Blood Transfusion Historic and Forecast Sales By Regions
  • 8.5. Fluid & Electrolyte Balance Historic and Forecast Sales By Regions
  • 8.6. Other Applications Historic and Forecast Sales By Regions

9. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY END-USER

  • 9.1. Overview By End-User
  • 9.2. Historical and Forecast Data Analysis By End-User
  • 9.3. Hospitals And Clinics Historic and Forecast Sales By Regions
  • 9.4. Ambulatory Surgery Centers Historic and Forecast Sales By Regions
  • 9.5. Home Care Setting Historic and Forecast Sales By Regions

10. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE INTRAVENOUS SOLUTIONS COMPANIES

  • 11.1. Intravenous Solutions Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF INTRAVENOUS SOLUTIONS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Ajinomoto Co Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Amanta Healthcare
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Axa Parenterals Ltd
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. B.Braun Melsungen AG
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Baxter International Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Fresenius Kabi USA LLC
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Grifols S.A.
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. ICU Medical Inc
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. JW Life Science
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Otsuka Pharmaceutical Co. Ltd
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Pfizer Inc
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies